Allurion Technologies’ CFO, Christopher Geberth, is resigning to explore new opportunities, effective November 13, 2024, but will continue as a consultant during the transition. CEO Shantanu ...

Weight-loss tech company Allurion Technologies has expanded its board ... Richey has served as president and CEO of Woburn-based medical technology company Cytrellis Biosystems and in several ...

In other recent news, Allurion Technologies reported its fourth-quarter 2024 earnings, revealing a decrease in revenue to $5.6 million from $8.2 million in the same quarter of the previous year.

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

The CEO of Allurion, Dr. Shantanu Gaur ... in obesity care if the study confirms the preliminary findings. Allurion Technologies is focused on ending obesity through its innovative weight-loss ...

--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE ... Allurion’s Founder and CEO. "Adrian joins us at an extremely important time – where the obesity market is expanding by the day ...

Allurion Technologies ALUR shares are moving higher ... maintaining or even increasing muscle mass. Dr. Shantanu Gaur, CEO of Allurion, stated that the planned study aims to confirm whether ...

Allurion Technologies (NYSE ... Dr. Shantanu Gaur, Founder and CEO of Allurion, emphasized the significance of maintaining lean muscle mass during weight loss. He highlighted the potential ...

"We are thrilled the Allurion Balloon will once again serve French patients as a clinically proven treatment for obesity," said Dr. Shantanu Gaur, Founder and CEO of Allurion. "Historically ...

Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock View all comments (0) 0 ALUR-7.05% In a recent transaction filed with the Securities and Exchange Commission, Gaur Shantanu, the ...

Allurion Technologies CEO Gaur Shantanu acquires $26,800 in stock Open in App ...